Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 2 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar mchedester (68.35) Submitted: 3/30/2013 8:58:03 PM : Outperform Start Price: $48.56 INFI Score: -14.25

Heavy insider buying with good clinical results.

Featured Broker Partners


Advertisement